Acta Scientific Microbiology (ASMI) (ISSN: 2581-3226)

Review Article Volume 4 Issue 2

COVID-19 in Eastern Mediterranean Region: A Prospect to Better Learning

Sharadambal Ramaseri Sunder1*, Satya Sudheer Pydi2, Devender Bansal1 and Elmoubasher Abu Baker Abd Farag1

1Ministry of Public Health, Doha, Qatar
2Sedeer Medical Services and Trading LLC, Doha, Qatar

*Corresponding Author: Sharadambal Ramaseri Sunder, Department of Communicable Diseases Control Programs, Ministry of Public Health, Doha, Qatar.

Received: December 02, 2020; Published: January 30, 2021



Background: The SARS CoV-2 (COVID-19) pandemic has triggered a severe economic contraction and public health concerns in Eastern Mediterranean Region (EMR) by challenging each country’s ability to cope up to the infection. Situations are apparently not similar across all the countries in the region. At the early phases of the outbreak, many countries followed strict containment measures to limit the spread of this virus. As the numbers were raising drastically, all the countries carefully strategized various methods to contain the virus. In order to battle this pandemic on all fronts, awareness of aspects influencing the transmission and its management options are critically essential.

Aim: This study aimed to emphasize on the strategies that would help in understanding the impact on preparedness, and response activities to contain the COVID-19 infection.

Methods: We conducted a fast-paced review of articles published from December, 2019 to August, 2020 on SARS-COV-2 and COVID-19. Publications ranging from observational to experimental studies, short communications, review articles, letters to editor and perspectives with respect to Eastern Mediterranean region were included.

Results: The outcomes were concerning to risk assessment, preparedness, response, and control measures in relation to COVID-19 in EMR and recommendations pertaining to wellbeing.

Conclusion: There is a desperate need of regional cooperation to protect the health of the people living in EM region. COVID-19 outbreak has triggered a clear need of detection, prevention and control strategies of zoonotic infections which would emerge in future.


Keywords: COVID-19; WHO- EMR; Risk Factors; Preparedness; Response



  1. Dhama K., et al. “SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus”. Travel Medicine and Infectious Disease 37 (2020): 101830.
  2. Coronavirus disease (COVID-19) Situation Report - 165, World Health Organization (2020).
  4. Badur S., et al. “Systematic review of the rotavirus infection burden in the WHO-EMRO region”. Human Vaccines and Immunotherapeutics11 (2019): 2754-2768.
  5. Al-Rousan N and Al-Najjar H. “Is visiting Qom spread CoVID-19 epidemic in the Middle East?” European Review for Medical and Pharmacological Sciences 24 (2020): 5813-5818.
  6. Malik MR., et al. “Novel coronavirus infection in the Eastern Mediterranean Region: time to act”. Eastern Mediterranean Health Journal1 (2013): S31-S38.
  7. Velavan TP and Meyer CG. “The COVID-19 epidemic”. Tropical Medicine and International Health3 (2020): 278-280.
  8. Fang Y., et al. “Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR”. Radiology 296 (2020): E115-E117.
  9. Kickbusch I., et al. “Covid-19: how a virus is turning the world upside down”. British Medical Journal 369 (2020): m1336.
  10. Lassoued A., et al. “Dataset on the COVID-19 Pandemic Situation in Tunisia with Application to SIR Model”. Med Rvix preprint (2020).
  11. Coronavirus disease (COVID-19) Situation Report – 82, World Health Organization (2020).
  12. Safadi MA. “The intriguing features of COVID-19 in children and its impact on the pandemic”. The Journal of Pediatrics 96 (2020): 265-268.
  13. Heymann DL and Shindo N. “COVID-19: what is next for public health?” Lancet10224 (2020): 542-545.
  14. Park M., et al. “COVID-19: Lessons from SARS and MERS”. European Journal of Immunology 50 (2020): 308-316.
  15. Kassahun B., et al. “Review on coronavirus, a middle east respiratory syndrome (MERS-CoV)”. Online Journal of Animal and Feed Research 1 (2020): 01-11.
  16. Killerby ME., et al. “Middle east respiratory syndrome coronavirus transmission”. Emerging Infectious Diseases2 (2020): 191-198.
  17. Mahase E. “Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate”. British Medical Journal 368 (2020): m641.
  18. Walker K. “Stricter control of wildlife trade needed to reduce virus risk”. Nature Middle East (2020).
  19. Lee A. “Wuhan novel coronavirus (COVID-19): why global control is Challenging?” Public Health 179 (2020): A1-A2.
  20. Reyad O. “Novel Coronavirus COVID-19 Strike on Arab Countries and Territories: A Situation Report I”. arXiv (2020).
  21. Zhuanga Z., et al. “Preliminary estimation of the novel coronavirus disease (COVID- 19) cases in Iran: A modelling analysis based on overseas cases and air travel data”. International Journal of Infectious Diseases 94 (2020): 29-31.
  22. Lynch M. “The COVID-19 Pandemic in the Middle East and North Africa”. The Project on Middle East Political Science (2020).
  23. Mikhael EM and Al-Jumaili AA. “Can developing countries face novel coronavirus outbreak alone? The Iraqi situation”. Public Health in Practice 1 (2020): 100004.
  24. Gele A. “What works where in prevention of Covid-19: The case of Somalia”. Eastern Mediterranean Health Journal 26 (2020): 5.
  25. Memish ZA., et al. “Hajj: infectious disease surveillance and control”. Lancet 383 (2014): 2073-2082.
  26. Al-Tawfiq JA and Memish ZA. “COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: prevention and therapeutic strategies”. International Journal of Antimicrobial Agents 55 (2020): 105968.
  27. Yezli S and A Khan. “COVID-19 social distancing in the Kingdom of Saudi Arabia: Bold measures in the face of political, economic, social and religious challenges”. Travel Medicine and Infectious Disease (2020).
  28. Coronavirus disease 2019 (COVID-19) strategic preparedness and response plan: Accelerating readiness in the Eastern Mediterranean Region (2020).
  29. Hasab A., et al. “Situational Analysis and Epidemic Modeling of COVID-19 in Egypt”. Journal of High Institute of Public Health1 (2020): 46-51.
  30. Karamouzian M and Madani N. “COVID-19 response in the Middle East and north Africa: challenges and paths forward”. Lancet GH7 (2020): E886-E887.
  31. Hariri M., et al. “The COVID-19 Forecast in Northwest Syria. The Imperative of Global Action to Avoid Catastrophe”. Med Rvix preprint (2020).
  32. Brennan R., et al. “Responding to health emergencies in the Eastern Mediterranean region in times of conflict”. Lancet (2020).
  33. Daw MA. “Corona virus infection in Syria, Libya and Yemen; an alarming devastating threat”. Travel Medicine and Infectious Disease (2020).
  34. Lighter J., et al. “Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission”. Clinical Infectious Diseases (2020).
  35. Alalwan AA., et al. “A Hemodialysis Patient with Severe COVID-19 Pneumonia”. Cureus 5 (2020): e7995.
  36. Zhang Q and Song W. “The challenges of the COVID-19 pandemic: Approaches for the elderly and those with Alzheimer’s disease”. Med Communications (2020): 1-5.
  37. Taheri S., et al. “Managing diabetes in Qatar during the COVID-19 pandemic”. The Lancet Diabetes and Endocrinology6 (2020): 473-474.
  38. Hitch D., et al. “The Functional Impacts of the Covid-19 Pandemic: A Rapid Review (2020).
  40. Al-Sadeq DW and Nasrallah GK. “The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review”. International Journal of Infectious Diseases (2020).
  41. Al-Shamsi HO., et al. “Screening for COVID-19 in Asymptomatic Patients with Cancer in a Hospital in the United Arab Emirates 020”. JAMA Oncology (2020).
  42. Rahimi F and Abadi ATB. “Challenges of managing the asymptomatic carriers of SARS-CoV-2”. Travel Medicine and Infectious Disease (2020).
  43. Hargreaves S., et al. “Targeting COVID-19 interventions towards migrants in humanitarian settings”. The Lancet Infectious Diseases6 (2020): P645-P646.
  44. Roess A. “A look at Arab regional responses to COVID-19”. Nature Middle East (2020).
  45. Negm HM. “Could COVID-19 improve psychiatric awareness at the heart of the Middle East? – A personal reflection on Bahrain’s response”. Irish Journal of Psychological Medicine (2020): 1-8.
  46. Poole DN., et al. “Responding to the COVID-19 pandemic in complex humanitarian crises”. International Journal for Equity in Health 19 (2020): 41.
  47. Yirgu R., et al. “COVID-19: Initial synthesis of the epidemiology, pathogenesis, diagnosis, treatment, and public health control approaches”. The Ethiopian Journal of Health Development 2 (2020).
  48. Mahmud I and Al-Mohaimeed A. “COVID-19: Utilizing local experience to suggest optimal global strategies to prevent and control the pandemic”. International Journal of Health Sciences3 (2020).
  49. Badrfamy R and Zandifar A. “Coronavirus disease 2019 in Iran: the need for more attention to primary health care”. Public Health 182 (2020): 187.
  50. Al-Mandhari A., et al. “Coronavirus Disease 2019: preparedness and readiness of countries in the Eastern Mediterranean Region”. Eastern Mediterranean Health Journal 2 (2020): 136-137.
  51. Das HJ. “COVID-19: Developments in West Asia. Vivekananda International Foundation (2020).
  52. Ghanam R., et al. “COVID-19: SEIRD Model for Qatar COVID-19 Outbreak”. Letters in Biomathematics (2020).
  53. Saddik B., et al. “Assessing the influence of parental anxiety on childhood anxiety during the COVID-19 pandemic in the United Arab Emirates”. Med Rxiv (2020).
  54. Simpson PL and Butler TG. “Covid-19, prison crowding, and release policies”. British Medical Journal 369 (2020): m1551.
  55. Shekhar S., et al. “Hookah smoking and COVID-19: call for action”. Canadian Medical Association Journal 192 (2020): E462.
  56. Mousavi SH., et al. “The first COVID-19 case in Afghanistan acquired from Iran”. The Lancet Infectious Diseases 6 (2020): P657-P658.
  57. Alser O., et al. “Healthcare workers preparedness for COVID-19 pandemic in the occupied Palestinian territory: a cross-sectional survey”. Med Rxiv preprint (2020).
  58. Mohsen F., et al. “A Crisis within a Crisis: COVID-19 Knowledge and Awareness among the Syrian Population-A National Survey Assessment”. Research Sqaure (2020).
  59. Abdi - Soojeede MI. “A review of clinical manifestation on coronavirus disease (COVID-19) in Somalia”. Research Gate (2020).
  60. Mousa KNAA., et al. “Knowledge, Attitudes, and Practices Surrounding COVID-19 among Sudan Citizens during the Pandemic: An Online Cross-sectional Study”. Sudan Journal of Medical Sciences (2020).
  61. Portnoy J., et al. “Telemedicine in the Era of COVID-19”. The Journal of Allergy and Clinical Immunology: In Practice 8 (2020): 1489-1491.
  62. Le TT., et al. “The COVID-19 vaccine development landscape. nature reviews drug discovery”. 19 (2020): 305-306.
  63. Zaatar MT. “Charting the UAE’s battle against COVID-19”. Nature Middle East (2020).




Citation: Sharadambal Ramaseri Sunder., et al. “COVID-19 in Eastern Mediterranean Region: A Prospect to Better Learning". Acta Scientific Microbiology 4.2 (2021): 82-90.


Acceptance rate30%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US